Although the distribution and functions of HSP in breast cancer phenotypes are not known in any detail, HSP60 is overexpressed at the mRNA and protein levels during early steps of certain breast tumorigenesis, including breast ductal carcinoma in situ, and may be correlated with tumor growth and progression. Here, HSPD1 is linked to ductal breast carcinoma in situ.